skip navigationU S P T O SealUnited States Patent and Trademark Office TTABVUE logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
TTABVUE. Trademark Trial and Appeal Board Inquiry System
v2.5.0

Summary

Query: Correspondence Name contains all words: MICHAEL E. MANGELSON, ESQ.
Number of results: 10

Proceeding
Filing Date
Defendant(s),
Correspondent
Property(ies)
Plaintiff(s),
Correspondent
Property(ies)
78594859
01/24/2007
Ortho Development Corporation
Michael E. Mangelson, Esq. STOEL RIVES LLP
Mark: C-LIF S#:78594859
DePuy, Inc.
Joseph D. Lewis Barnes & Thornburg LLP
91175124
01/15/2007
Ortho Development Corporation
Michael E. Mangelson, Esq. STOEL RIVES LLP
Mark: C-LIF S#:78594858
DePuy, Inc.
Joseph D. Lewis Barnes & Thornburg LLP
78594858
08/09/2006
Ortho Development Corporation
Michael E. Mangelson, Esq. STOEL RIVES LLP
Mark: C-LIF S#:78594858
DePuy, Inc.
Joseph D. Lewis Barnes & Thornburg LLP
78587671
12/20/2005
Therion Biologics Corporation
Cynthia Johnson Walden, Fish & Richardso
Mark: XAEGO S#:78587671
DBC, LLC
Michael E. Mangelson, Esq. Stoel Rives LLP
91163910
12/13/2004
NPS Pharmaceuticals, Inc.
Michael E. Mangelson, Esq. Stoel Rives LLP
Mark: OSTACT S#:78209649
Ligand Pharmaceuticals, Inc
Peter J. Lynfield Abelman Frayne & Schwab
91161239
07/12/2004
NPS Pharmaceuticals, Inc.
Michael E. Mangelson, Esq. Stoel Rives LLP
Mark: GIOTEC S#:78169496
ANGIOTECH PHARMACEUTICALS INC
Kevin S. Costanza Seed IP Law Group
78169496
02/17/2004
NPS Pharmaceuticals, Inc.
Michael E. Mangelson, Esq. Stoel Rives LLP
Mark: GIOTEC S#:78169496
ANGIOTECH PHARMACEUTICALS INC
Kevin S. Costanza Seed IP Law Group
ANGIOTECH PHARMACEUTICALS INC.
KEVIN S COSTANZA SEED INTELLECTUAL PROPERTY LAW GROUP PLL
78169493
02/03/2004
NPS Pharmaceuticals, Inc.
Michael E. Mangelson, Esq. Stoel Rives LLP
Mark: ZELBRIA S#:78169493
Pfizer Inc.
J. Paul Williamson Fulbright & Jaworski L.L.P.
G.D. Searle LLC
J. Paul Williamson Fulbright & Jaworski L.L.P.
78209657
10/14/2003
NPS Pharmaceuticals, Inc.
Michael E. Mangelson, Esq. Stoel Rives LLP
Mark: ZYSTUS S#:78209657
Novartis AG
Steven H. Hartman Novartis
78209649
10/10/2003
NPS Pharmaceuticals, Inc.
Michael E. Mangelson, Esq. Stoel Rives LLP
Mark: OSTACT S#:78209649
Ligand Pharmaceuticals, Inc
Peter J. Lynfield Abelman Frayne & Schwab

Results as of 11/22/2024 02:47 PMSearch again
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY POLICY